ARTICLE | Company News
Pharmstandard, Biolek PJSC deal
January 24, 2011 8:00 AM UTC
Pharmaceutical company Pharmstandard acquired a 55% stake in Biolek. The acquisition will add vaccines and oncology drugs to Pharmstandard's portfolio and increase its sales presence in Russia. Furthe...